USCWA
U.S. Capital Wealth Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.8M | Sell |
68,894
-17,458
| -20% | -$3.24M | 0.37% | 61 |
|
2025
Q1 | $18.1M | Sell |
86,352
-44,566
| -34% | -$9.34M | 0.55% | 37 |
|
2024
Q4 | $23.3M | Buy |
130,918
+3,120
| +2% | +$554K | 0.72% | 18 |
|
2024
Q3 | $25.2M | Sell |
127,798
-903
| -0.7% | -$178K | 0.89% | 15 |
|
2024
Q2 | $22.1M | Sell |
128,701
-883
| -0.7% | -$151K | 0.84% | 17 |
|
2024
Q1 | $23.6M | Sell |
129,584
-18,249
| -12% | -$3.32M | 0.91% | 19 |
|
2023
Q4 | $22.9M | Sell |
147,833
-45,031
| -23% | -$6.98M | 0.91% | 16 |
|
2023
Q3 | $28.7M | Sell |
192,864
-4,399
| -2% | -$656K | 1.29% | 9 |
|
2023
Q2 | $26.6M | Sell |
197,263
-11,524
| -6% | -$1.55M | 1.26% | 9 |
|
2023
Q1 | $33.3M | Buy |
208,787
+5,541
| +3% | +$883K | 1.54% | 8 |
|
2022
Q4 | $32.8M | Sell |
203,246
-21,116
| -9% | -$3.41M | 1.52% | 7 |
|
2022
Q3 | $30.1M | Buy |
224,362
+1,791
| +0.8% | +$240K | 1.52% | 7 |
|
2022
Q2 | $34.1M | Sell |
222,571
-13,385
| -6% | -$2.05M | 1.5% | 7 |
|
2022
Q1 | $38.3M | Sell |
235,956
-5,966
| -2% | -$967K | 1.4% | 9 |
|
2021
Q4 | $32.8M | Sell |
241,922
-15,640
| -6% | -$2.12M | 1.3% | 9 |
|
2021
Q3 | $27.8M | Buy |
+257,562
| New | +$27.8M | 1.21% | 10 |
|